INTRODUCTION AND OBJECTIVES: The molecular mechanisms of muscle invasion in bladder cancer (BC) are still unknown. Based on the microRNA (miRNA) signature of BC by deep sequencing, we recently found that several double-stranded mature miRNAs derived from the same pre-miRNAs acted as tumor suppressors by regulating common target genes. In this study, we focused on miR-199 family members (miR-199a-3p/-5p and miR-199b-3p/-5p) that were downregulated in the signature. The aim of this study was to investigate the functional role of miR-199 family members and to identify molecular targets that contribute to tumor invasion in BC.
INTRODUCTION AND OBJECTIVES: Human bladder cancer (BCa) is a common disease, with the etiology and mechanism unknown. Accumulated evidence shows that micro RNAs (miRNAs) play vital roles and can be used as biomarkers for many types of cancers. The aim of this study is to use bioinformatics analysis to identify the key miRNAs and potential target genes, as well as studying the underlying mechanisms for BCa.
METHODS: The raw sequencing data and clinical information were downloaded from TCGA database. The miRNA profiles were normalized by log2 transformed. Subsequently, a prognostic miRNA signature was constructed, and the miRNA signature could calculate a risk score for each bladder cancer patient. The target genes of prognostic miRNAs were predicted using TargetScan, miRDB, PicTar, and miRanda online analysis tools. To further enhance the bioinformatics analysis reliability, the overlapping target genes were identified using Venn diagram and the Database for Annotation, Visualization and Integrated Discovery bioinformatics tool.
RESULTS: In the present study, a total of 407 samples were enrolled and 348 differentially expressed miRNAs were identified between bladder cancer tissues and normal tissues, including 264 upregulated miRNAs and 84 down-regulated miRNAs. Meanwhile, the Kaplan-Meier survival method revealed that the prognostic function of four miRNAs . miR-217, miR-33b and miR-615 were positively associated to overall survival (OS), while miR-378c was reversely correlated with OS. Interestingly, univariate and multivariate Cox regression analyses showed that the four-miRNA (miRNA-217, miRNA-378c, miR-33b and miRNA-615) signature was an independent prognostic factor in bladder cancer. The functional enrichment analysis showed that the target genes of four miRNAs might be involved in various pathways related to cancer signaling pathways, including Notch signaling pathway, PI3K-Akt signaling pathway, p53 signaling pathway, cGMP-PKG signaling pathway, FoxO and signaling pathway.
CONCLUSIONS: This study identified, for the first time, a fourmiRNA signature as a potential prognostic predictor for bladder cancer patients. Further studies are needed to validate our findings in large sample size, and function investigations are also required to explore the molecular mechanisms of these miRNAs in bladder cancer progression.
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MP58-13 THE ROLE OF G8 SCREENING TOOL IN ELDERLY POPULATION UNDERGOING RADICAL CYSTECTOMY: PRELIMINARY EVALUATION
Riccardo Boschian, Nicola Pavan*, Enrica Verzotti, Tommaso Silvestri, Fabio Traunero, Giovanni Liguori, Carlo Trombetta, Trieste, Italy INTRODUCTION AND OBJECTIVES: The G8 screening tool represents a valid instrument for the identification of functional decline in oncological geriatric patients (pts). Recently it has demonstrated good predictive value in surgery to identify fragile pts candidates for oncological abdominal surgery. Our study has the objective to define if G8 score is a good tool to identify the risk of post operative complications in elderly pts (¼ 70 years) undergoing radical cystectomy (RC).
METHODS: From January 2012 to August 2017 we recruited 56 pts 70 yrs or older at the surgical time, undergone RC. Median age was 76 yrs (SD 4,37). The G8 screening questionnaire was perfomed to all patients preoperatively, and fragile pts were identified with a score ¼ 14. We registered intra operative complications, post operative complications and their gravity using Clavien Dindo scale, estimated glomerular filtration rate (eGFR) and its variation postoperatively, length of hospital stay after surgery and readmission rate within 30 days. We compared the clinicalpathological data between the frail (G8 score <¼14) and not frail (G8 score >14) group. Statistical analysis was made by computing software SPSS.
RESULTS: Median preoperative G8 score was 13,65 (SD 2,3). Pts were divided in fragile (N¼35, 62,5%) and fit (N¼21, 37,5%). Intra operative complications were registered in 1 pts (2,8 %) with G8 score ¼14 and 0 pt (0%) with G8>14 (p¼ 0,625). Post operative complications occurred in 24 pts (68,5 %) with G8 score ¼14 and 8 pts (38,09 %) with G8>14 (p¼0,025), 12 and none of them had a Clavien Score ¼ 3 respectevely (p¼ 0,015). Postoperative eGFR was 61,45 (SD 29,2) in G8¼14 group and 57,66 (SD 25,84) in G8>14 group (p¼0,62) and median variation between pre and postoperative eGFR was 7,8 (SD 27,43) and 8,0 (SD 26,01) for each group (p¼ 0,97). Median hospital stay was 25,45 days (SD 11,01) for fragile pts and 24,23 days (SD 11,32) for fit pts (p¼0,69). 5 pts (14,28 %) with G8score¼14 were readmitted within 30 days of discharge, and for 6 pts (28,57 %) with G8score>14 was necessary a new hospitalization (p¼ 0,298). No significative difference was registered for overall mortality (p¼ 0,23) and cancer related mortality (p¼ 0,53) between the two groups. Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 THE JOURNAL OF UROLOGY â e777 CONCLUSIONS: The G8 screening tool represents a good predictive instrument for RC morbidity, identifying fragile pts at risk of post operative complications and their severity. Further analyses are necessary to confirm the data obtained from this preliminary study.
Source of Funding: None

MP58-14 USING T CELL RECEPTOR SEQUENCING TO CHARACTERIZE THE HOST IMMUNE RESPONSE IN UROTHELIAL CARCINOMA
Alexander Sankin*, Damini Chand, Mark Schoenberg, Xingxing Zang, Bronx, NY INTRODUCTION AND OBJECTIVES: High T cell receptor (TCR) repertoire clonality is associated with clinical response to immune checkpoint blockade in bladder cancer (Funt et al ASCO 2016) . We hypothesized that T cell repertoire is more clonal in tumors than in benign inflammation.
METHODS: After obtaining IRB approval, we prospectively identified n¼12 patients with bladder lesions at Montefiore Medical Center undergoing transurethral resection. Specimens were collected at time of transurethral resection and frozen and stored at -80C. DNA was extracted and high throughput DNA sequencing of the CDR3 region of the TCR beta chain using the immunoSEQ assay (Adaptive Biotechnologies) was performed. T cell fraction, clonal dominance, and maximum frequency of TCR clone were assessed.
RESULTS: There was an even distribution of specimens across all pathologic stages: 3/12 were T0, 3/12 were Ta, 3/12 were T1, and 3/ 12 were T2 or greater. The median number of productive TCR rearrangements sequenced in each sample in urothelial carcinoma specimens (UCþ) and benign (UC-) specimens was 5,569 and 25,872 respectively. The median number of unique TCR rearrangements sequenced in UCþ and UC-specimens was 3,069 and 9,680, respectively. The median tumor infiltrating lymphocyte (TIL) percentage in UCþ and UC-specimens was 2% and 12%, respectively. The UCþ specimens demonstrated clonality as evidenced by identification of a specific T cell clone being present in up to 17% of the total TIL pool; in contrast, the frequency of the max T cell clone was 2% in UC-specimens (Figure 1) . CONCLUSIONS: Primary urothelial tumors contain clonally expanded T cell populations that are not present in benign urothelial inflammation. These data support the hypothesis that bladder tumors induce an antigen driven immunogenic host response, in contrast to the benign inflammatory response, which does not appear to demonstrate any T cell clonal dominance. Future studies should be aimed to validate these results and to identify which tumor derived antigens are of clinical significance.
Source of Funding: Montefiore Medical Center and Albert Einstein College of Medicine Department of Urology
MP58-15 M2 AND M3 MUSCARINIC RECEPTOR EXPRESSION IN BLADDER TUMOR
Mehmet Kazim Asutay*, Sanliurfa, Turkey; Banu Aydin, Hasan Toper, Deniz Filinte, Istanbul, Turkey; H€ ulya Cabadak, Ilker Tinay, istanbul, Turkey INTRODUCTION AND OBJECTIVES: Bladder cancer is one of the most common urogenital cancers of Western society. Transitional cell carcinoma is a heterogeneous cancer type, which costitudes 90% of all bladder cancers. Urothelial cells are continuously in relation with several signal molecules and neurotransmitters. One of these, muscarinic acetyl choline receptors, are expressed on both urothelial cells and detrusor muscle and play a great role in human bladder physiology. Specifically M2 and M3 type receptors are the most common receptors of bladder. M2 receptors are specially found on umbrella cells on the mucosa layer of bladder and almost up to three times more frequent than M3 receptors. Some of the recent studies show the importance and role of muscarinic receptors on some types of disease. In this study muscarinic receptor expression, namely M2 and M3 subtypes of muscarinic receptors were analyzed on bladder tumor samples.
METHODS: In order to have a strong evidence of M2 and M3 subtypes in bladder tumors, the samples were analyzed both with Western blot technique and with immunohistochemistry. Bladder tumor samples, which are collected by transurethral resection of the bladder, are homogenized, centrifuged and preserved at -80?C. Protein component was analyzed via Lowry method. p< 0.05 data were accepted as statistically significant. The samples also were analyzed by pathologists with immunohistochemistry technique for M2 and M3 muscarinic receptor expression.
RESULTS: Data of 45 patients were analyzed. Statistical analyses show that patients with pathological T2 stage and with progressed disease during follow-up have greater M2 receptor value which is statistically significant. There was no relation between M3 muscarinic receptor level and tumor grade/stage or progression rate. These results were not dependent by patient age or lower urinary tract symptoms. Progression rate was found higher in patients with higher M2 muscarinic receptor levels on bladder tissue samples.
CONCLUSIONS: M2 and M3 muscarinic receptors not only play a great role on bladder functions but also also may be important for bladder cancer pathophysiology though, their role in the development of blader cancer has not been defined yet. This current trial may indicate M2 receptors to be a potential treatment target for bladder cancer.
